On December 4, 2025, Sky Labs (CEO Jack Byunghwan Lee) announced that its ring-type blood pressure monitoring device, 'CART BP', has successfully measured blood pressure in a microgravity environment ...
BX, APO and KKR to join BoE private credit stress test examining how the fast-growing sector will hold up under severe financial strain.
Perspire Sauna Studio Joins Erewhon Lifestyle Collective to Expand Access to Science-Backed Wellness
Perspire Sauna Studio, the country's largest sauna franchise specializing in full spectrum infrared (IR) and red-light therapy (RLT), and contrast therapy through SNO Showers, today announced it has ...
BGB-16673 showed high overall response rates in relapsed/refractory CLL/SLL, with a notable 94.4% response at the 200-mg dose level. Safety analysis revealed that 95.6% of patients experienced ...
News-Medical.Net on MSN
Study finds GLP-1 drugs improve strength and reverse aging biology in mice
Researchers showed that GLP-1 receptor agonism counteracts aging across multiple organs in mice, improving strength and reversing molecular aging signatures without meaningful effects on body weight.
Updated data expands clinically meaningful results available from FIREFLY-1 pivotal trial 77% of patients who entered the ...
Objective To develop and validate a 10-year predictive model for cardiovascular and metabolic disease (CVMD) risk using ...
Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the ...
Women who used a GLP-1 prior to pregnancy and stopped therapy 1 to 2 years before delivery had increased risk for preeclampsia, but reduced risk for developing gestational diabetes, according to study ...
Introduction Sports-related concussions (SRCs) are frequently under-reported in youth sports, especially football, due to limited awareness, inconsistent reporting practices and a lack of medical ...
Ontada is highlighting its research capabilities at ASH with nine accepted abstracts on topics such as real-world uptake and patient characteristics of bispecific antibodies in relapsed / refractory ...
Novo Nordisk A/S remains a Strong Buy despite semaglutide's Alzheimer's trial miss. Click for NVO growth drivers, solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results